The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer

The discovery of potent EGFR-tyrosine kinase inhibitors (EGFR-TKIs) has revolutionized the treatment of EGFR-mutated lung cancer. Despite the fact that EGFR-TKIs have yielded several significant benefits for lung cancer patients, the emergence of resistance to EGFR-TKIs has been a substantial impedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moonmuang, Sutpirat, Tantraworasin, Apichat, Orrapin, Santhasiri, Udomruk, Sasimol, Chewaskulyong, Busyamas, Pruksakorn, Dumnoensun, Chaiyawat, Parunya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003401/
https://www.ncbi.nlm.nih.gov/pubmed/36902280
http://dx.doi.org/10.3390/ijms24054827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003401/
https://www.ncbi.nlm.nih.gov/pubmed/36902280
http://dx.doi.org/10.3390/ijms24054827

Ejemplares similares